Other proteins and pathways related to metabolism have also been suggested as potential therapeutic targets for cancer cells lacking SETD2, including the PI3K pathway, WEE1, and the mTORC1 signaling pathway (W et al., 2023; Pfister et al., 2015; Terzo et al., 2019). The gene discussed is SETD2; the disease is cancer.